Table 2. Perioperative outcomes of the patients undertaking hybrid uniportal RATS.
Characteristics | Total (n=40) |
---|---|
Resection range, n (%) | |
Bilobectomy | 1 (2.5) |
Lobectomy + wedge resection | 2 (5.0) |
Segmentectomy + wedge resection | 3 (7.5) |
Lobectomy | 23 (57.5) |
Bronchial sleeve lobectomy | 1 (2.5) |
Segmentectomy | 10 (25.0) |
Conversion to biportal access, n (%) | 1 (2.5) |
Operation duration (min), median [IQR] | 76 [61–99] |
Intraoperative blood loss (mL), median [IQR] | 50 [50–50] |
LOS (days), median [IQR] | 3 [2–4] |
Drainage duration (days), median [IQR] | 3 [2–4] |
Drainage volume (mL), median [IQR] | 263 [155–491] |
Postoperative complicationsa, n (%) | |
Clavien-Dindo I–II | 11 (27.5)b |
Pneumonia | 6 (15.0) |
Transient elevation of serum creatinine | 5 (12.5) |
Atrial fibrillation | 2 (5.0) |
Clavien-Dindo III–IV | 0 (0.0) |
Administration of extra analgesic, n (%) | 6 (15.0) |
Readmission within 30 days, n (%) | 0 (0.0) |
Mortality within 30 days, n (%) | 0 (0.0) |
a, postoperative complications were evaluated in accordance with Clavien-Dindo classification; b, one patient experienced both transient elevation of serum creatinine and pneumonia, and another patient also experienced both transient elevation of serum creatinine and atrial fibrillation. RATS, robot-assisted thoracoscopic surgery; IQR, interquartile range; LOS, length of stay.